Is it normal to feel weak during treatment with Selinexor?

Selinexor (Selinexor) is a selective nuclear export inhibitor (XPO1 inhibitor), mainly used to treat hematological malignancies such as relapsed or refractory multiple myeloma and certain lymphomas. This drug induces tumor cell apoptosis by blocking the extranuclear transport of tumor suppressor proteins and causing them to accumulate in the nucleus. Although selinesol has achieved positive therapeutic effects in some patients, physical weakness or fatigue is one of the more common adverse reactions while taking the drug.

Clinical studies and real-world data show that fatigue, decreased energy, loss of appetite, and weight loss are common side effects of selinexol, especially during long-term treatment. This feeling of weakness may be related to the effects of the drug on the central nervous system, gastrointestinal tract, and bone marrow hematopoietic function. For example, mild dehydration, electrolyte imbalance, or insufficient nutritional intake caused by drugs may aggravate the patient's physical exertion and lead to an increased sense of weakness.

While this weakness is partly an expected reaction to medications, it doesn't mean it should be ignored. If the degree of fatigue affects daily activities, the quality of life is significantly reduced, or is accompanied by other serious symptoms (such as persistent nausea, vomiting, confusion, etc.), the doctor should be informed in time. The doctor may recommend temporarily adjusting the dose, extending the medication interval, or providing nutritional support, fluid rehydration, electrolyte balance and other symptomatic treatments to help relieve discomfort.

In short, physical weakness during selinesol treatment is a common discomfort reaction, but it can be alleviated through timely evaluation and appropriate intervention. Patients and family members should pay close attention to physical changes, pay attention to maintaining nutrition and rest, avoid strenuous activities, and maintain good communication with the medical team to ensure that the entire course of treatment is completed in a safe and controllable manner, thereby increasing the possibility of successful treatment.

Reference materials:https://www.drugs.com/